Russell Investments Group, Ltd.

Position in GALT — Galectin Therapeutics Inc

CIK 1692234 Seattle, WA

Position in GALT

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$18,438

+$18,042 QoQ

Shares Held

3,974

+2698.6% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#85

of 98 holders

Holding Since

Sep 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. GALT ranks #264 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,438	3,974	+2698.6%	Shares	Defined	2026-08-06
2026-03-31	$396	142	-99.2%	Shares	Defined	2026-05-08
2025-12-31	$75,187	18,074	+9997.2%	Shares	Defined	2026-02-17
2025-09-30	$758	179	0.0%	Shares	Defined	2025-11-13
2025-06-30	$377	179	-65.5%	Shares	Defined	2025-08-13
2025-03-31	$633	519	-29.9%	Shares	Defined	2025-05-13
2024-09-30	$2,035	740	-99.3%	Shares	Defined	2024-11-13
2020-12-31	$237,608	106,075	0.0%	Shares	Defined	2021-02-08
2020-09-30	$283,220	106,075	—	Shares	Defined	2020-11-09
No filing history on record for this holder in this stock.